Top Page
Red Light Holland
(TRIP)
Red Light Holland (TRIP) vs. iShares MSCI Canada ETF (EWC)
Red Light Holland Business Overview & Revenue Model
Red Light Holland Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.94M | 4.94M | 4.75M | 3.95M | 2.33M | 110.96K |
| Gross Profit | 1.91M | 1.91M | 2.02M | 1.71M | 617.68K | 19.35K |
| EBITDA | -3.59M | -3.35M | -6.58M | -4.32M | -8.55M | -4.61M |
| Net Income | -4.04M | -4.04M | -7.63M | -5.40M | -14.37M | -1.64M |
Balance Sheet | ||||||
| Total Assets | 21.22M | 21.22M | 24.08M | 30.14M | 32.94M | 36.30M |
| Cash, Cash Equivalents and Short-Term Investments | 12.27M | 12.27M | 14.17M | 18.53M | 26.62M | 32.78M |
| Total Debt | 2.18M | 2.18M | 1.72M | 1.77M | 1.50M | 866.50K |
| Total Liabilities | 3.87M | 3.87M | 3.82M | 3.80M | 3.78M | 2.24M |
| Stockholders Equity | 17.35M | 17.35M | 20.07M | 26.06M | 28.48M | 34.06M |
Cash Flow | ||||||
| Free Cash Flow | -2.01M | -2.01M | -3.92M | -6.45M | -5.28M | -3.63M |
| Operating Cash Flow | -1.48M | -1.48M | -3.23M | -4.39M | -4.88M | -3.36M |
| Investing Cash Flow | -525.40K | -525.40K | -650.43K | -3.17M | -582.74K | -201.55K |
| Financing Cash Flow | 445.17K | 445.17K | -206.95K | -114.16K | 451.76K | 32.78M |
Red Light Holland Technical Analysis
Red Light Holland Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | C$11.38M | ― | -7.15% | ― | 10.84% | 48.57% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | C$10.09M | 15.79 | 11.57% | ― | -1.14% | ― | |
| ― | $9.92M | 3.85 | -4.55% | ― | 16.22% | -285.37% | |
| ― | $6.96M | -0.31 | -53.71% | ― | 26.36% | -8.21% | |
| ― | $14.43M | -3.89 | -19.44% | ― | -8.27% | 50.55% | |
| ― | C$5.29M | ― | -132.79% | ― | -46.59% | 9.48% |
Red Light Holland Corporate Events
Red Light Holland has secured a second United States Controlled Substances import permit through its partner, Irvine Labs, allowing for a larger shipment of psilocybin truffles from its Netherlands facility. This development marks significant progress in their research and development efforts, enabling the advancement of proprietary processes for potential medical-grade manufacturing applications. The increased import quantity reflects growing confidence in the company’s ability to provide high-quality psilocybin materials and supports their aim to develop standardized products for emerging therapeutic markets.
Red Light Holland has received an official Certificate of Analysis (COA) through its partner, Irvine Labs, confirming the psilocybin potency and process validation for potential medical-grade manufacturing applications. This development marks a significant step in their partnership, as they aim to create standardized psilocybin products for emerging therapeutic markets and clinical trials, with plans for larger psilocybin exports under Irvine Labs’ DEA quota.
Red Light Holland’s subsidiary, Happy Caps Mushroom Farm, has expanded its partnership with Safeway, increasing its presence to 123 stores across Oregon and Washington State. This expansion, which represents an 86% increase in store count, is set to roll out in late fall and the holiday season of 2025, highlighting the growing consumer demand for functional mushroom products in the health and wellness market.
Red Light Holland has reported its financial results for the first quarter of 2026, highlighting a decrease in revenue and gross profit compared to the previous year. Despite these challenges, the company has made strategic moves, including entering the U.S. retail market through Albertsons, launching new products like Health Canada-approved mushroom gummies, and investing in Bitcoin as a financial strategy. The company is also exploring M&A opportunities and remains optimistic about future growth in the psychedelic and functional mushroom sectors.
Red Light Holland Corp. has announced progress in its Bitcoin balance sheet strategy by purchasing 10,600 shares of the iShares Bitcoin ETF and setting up infrastructure with a major exchange to leverage Arch Public’s algorithmic trading strategies. This initiative reflects the company’s commitment to integrating blockchain and cryptocurrency into its operations, aligning with its vision of innovation and long-term value creation in the psychedelics and wellness markets.
Red Light Holland Corp. has expressed optimism following the U.S. DEA’s decision to forward a psilocybin rescheduling petition to the Department of Health and Human Services for review. This move could potentially reclassify psilocybin from Schedule I to Schedule II, acknowledging its medical applications. Such a change would expand access to treatments for conditions like anxiety, depression, and PTSD, and facilitate research and development in the psychedelic sector. Red Light Holland, in partnership with Irvine Labs Inc., is advancing psychedelic research and has validated the potency of its psilocybin truffles for potential medical-grade applications.
Red Light Holland has received initial testing results from Irvine Labs, confirming the compatibility of its naturally derived psilocybin products with potential medical grade manufacturing processes. This development marks a significant step in their partnership, focusing on creating standardized psilocybin products for therapeutic markets, with Irvine Labs advancing proprietary dehydration and packaging processes to enhance product shelf life.
Red Light Holland’s CEO, Todd Shapiro, will participate in the Blockchain Futurist Conference in Miami, highlighting the intersection of blockchain technology and psychedelics. This participation underscores the company’s commitment to decentralized finance, enhancing operational stability and growth, and promoting personal sovereignty by reducing reliance on traditional financial systems.